info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +18317045538    uk UK: +441256636046    in IN: +918260836500
Home » Healthcare » Kidney Function Test Market Size, Global Forecast | Report 2030

Kidney Function Test Market By Test Type (Urine Tests, Blood Tests), By Product (Dipsticks, Reagents, Disposables) By Geography, Size, Share, Global Report, Forecast, 2021-2030

Published On: Apr-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 18147151

Report DescriptionTable of Contents

Industry Report and Statistics

The global kidney function test market will witness a robust CAGR of 6.63%, valued at $828.57 million in 2021, expected to appreciate and reach $1476.53 million by 2030, confirms Strategic Market Research. The rapid rising of the global industry is primarily attributed to some the factors like rising prevalence of hypertension and type-2 diabetes, rising prevalence of kidney disease, fast growth in the geriatric population of the country, and the rise of alcohol consumption is increasing the overall development of the market. According to a study advertised in medRXiv in Apr2020, COVID-19 urinary incontinence was commonly found in patients with many infectious and harmful diseases. In the age group of 0 to 12, exposure to the urinary tract COVID-19 has been detected among those who suffer from a little lite form of COVID-19. Urinary tract infections of COVID-19 were detected from day 1 to day 52 after the onset of the disease. Kidney function markers are used to determine how well the kidneys are working. There are both radioactive and non-radioactive indicators. They show the kidneys' glomerular filtration rate and their concentrating and diluting capacity (tubular function). Many people prefer to buy kidney function test over the counter than online. Kidney biopsy is a method that helps doctors identify the cause of kidney problems.

kidney function test market by share 2020-2030

 

Market Drivers

  • The National Kidney Foundation (NKF) and CVS Kidney Care, a Kidney Function test CVS is a Health brand have teamed up to launch a national campaign to increase awareness of kidney disease which affects over 37 million people in the United States. This, in turn, is driving the overall efficacy of the market extensively. Furthermore, one out of every three individuals in the United States, or 33%, is at risk of getting this life-threatening disease.

 

  • Moreover, due to the increase in privileges of kidney function tests at home, and theorising Research & Development initiatives for the overall growth of the novel products are prevised to boost the entire kidney function test market growth significantly throughout the forecasted period.

 

Market Restraints

  • The high cost of kidney disease diagnosis procedures and authoritarian synchronization are the key factors which are anticipated to hamper the market’s rise.

 

Market Opportunities

  • Several public-private firms are undertaking initiatives to smoothen the overall process of kidney disease testing for the country’s welfare. For example, in July 2020, the National Kidney Foundation (NKF) merged with the National Committee for Quality Assurance (NCQA) to initiate a brand-new kidney health appraisal quantitative, specifically for patients with Type-2 diabetes. The new recommendation proposes a routine test for types-2 Diabetes patients with kidney diseases. Such initiatives are anticipated to generate a remunerative environment for market growth.

 

Kidney Function Test Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

Market size value in 2021

USD 828.57 million

Revenue forecast in 2030

USD 1476.53 million

Growth rate

CAGR of 6.63%

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

Based By Test Type, Based By Product, Based on End-User, and By region.

Based By Test Type

Urine Tests, Blood Tests.

Based By Product

Dipsticks, Reagents, Disposables.

By By End-Use

Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes, Others.

By Region

North America, Europe, Asia-Pacific, and LAMEA

Country Scope

US, Mexico, Canada, Germany, UK, France, China, Japan, India etc.

Company Usability Profiles

UnititMedical, Sysmex Corporation, Siemens Healthcare GmbH, Hoffmann-La Roche Ltd., Randox Laboratories, Opti Medical, Nova Biomedical, Beckman Coulter, ARKRAY Inc.,Acon Laboratories,Abbott, Cook Medical, 77 Elektronika, Medical Care, Baxter,Boston Scientific.

Pricing and purchase options

Customized buying options are available to meet your exact research needs.

 

Market Analysis Of Different Segments Covered in the Report

Based on Test Type

  • Urine Tests

  • Blood Tests

Based on  Product:

  • Dipsticks

  • Reagents

  • Disposables

Based on  End-Use:

  • Hospitals

  • Diagnostic Laboratories

  • Research Laboratories and Institutes

  • Others

 

Regional Coverage Analysis

  • North America

  • United States

  • Canada

 

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Others

 

Europe

  • Germany

  • France

  • United Kingdom

  • Italy

  • Spain

  • Russia

  • Others

 

Latin America

  • Brazil

  • Mexico

kidney function test market by product 2020-2028

 

Segments Analysis & Insights

By Test Type - The market is divided into urine tests and blood tests. Urine protein, Creatinine Test (which usually lies between 0.8 to 1.2 in the normal cases, but it becomes abnormal when it results like kidney function test 3.3, kidney function test 1.6, kidney function test 1.5, kidney function test 1.3, kidney function test 1.4), and microalbumin tests are the three types of urine testing. Blood tests are divided into serum creatinine, glomerular filtration rate (GFR), and blood urea nitrogen (BUN). In 2017, the Kidney function test urine category was predicted to have the most significant market share. This segment is also expected to increase at the fastest CAGR during the projection period. The increasing use of urine dipstick analysis, the convenience of sample collection compared to blood tests that can cause discomfort and swelling, and the shallow risk of infection due to sample collection can all be related to the significant share of the urine test segment’s rapid growth rate. Renal scintigraphy is one of many imaging tests used to evaluate the kidneys.

 

By Product- Dipsticks, reagents, and disposables make up the market's product categories. The dipsticks segment is predicted to have the most significant kidney function test market share in 2017 and the highest CAGR over the forecast period. Moreover, dipstick testing's cost-effectiveness, which also accounts for its broad application worldwide, is one of the factors contributing to its substantial proportion of the market.

 

By End-Use- The market is divided into hospitals, diagnostics laboratories, and research laboratories and institutes based on end-users. The hospital sector is the market's most significant and fastest-growing segment. In 2020, the hospital sector had the most important market share of 53.89 per cent. This high percentage can be attributable to increased hospital visits as people become more aware of CKD and how to treat it.

 

By Region- North America is expected to have the most significant market share in 2017, followed by Europe. This substantial share can be linked to causes such as the rising incidence of chronic diseases, the increasing prevalence of hypertension, the increasing incidence of diabetes in the United States, and the Canadian government's increasing programs for kidney disease awareness and treatment. However, the Asia Pacific area is expected to have the most incredible CAGR during the projected period.

kidney function test market by end-user 2020-2028

Global Kidney Function Test Market Competitive Landscape Analysis

The market is working in terms of competition, and it consists of a lot of significant players in the market. In terms of industry, there are a lot of market players who are dominating the market.

kidney function test market by region 2020-2028

 

Recent Development

  • In Apr 2021, Eurofins Viracor collects acquiescence from the New York State Department of Health Clinical Laboratory Evaluation Program (CLEP) for the Viracor TRAC (Transplant Allograft Rejection Check) TruGraf blood gene expression test and donor-derived cell-free DNA test which help in evaluating the disapproval status in kidney transplant recipients.

  • In Mar 2021, Bio-Techne Corporation launched fundamental pragmatic data on its kidney translucent disapproval test, ExoTRU (Exosome Transplant Rejection Urine), defining that it is efficient in discerning between types of kidney disapproval, supplying condemning data to abet resolution-making and optimizing patient care.

 

Various Product that Key Industry Players Develop

Name of the product

Function

Key Players

Dipstick

Measuring the depth of a liquid

Honeywell, Vega, Hero MotoCorp Ltd.

Disposables

It decreases the dangers and risks to the communities.

.Citiwaste, Sanpro Waste, MedProWaste Disposal

Reagents

It is used to determine the presence or absence of a specific chemical substance.

Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Becton Dickinson & Company

 

Frequently Asked Question About This Report

b: The most vital players in the market are Unit Medical, Sysmex Corporation, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Randox Laboratories, Opti Medical, Nova Biomedical, Beckman Coulter, ARKRAY Inc., Acon Laboratories, Abbott, Cook Medical, 77 Elektronika, Medical Care, Baxter, Boston Scientific.

b: Based on the end-user, the ‘Research Laboratories and Institutes’ segment accounted for the highest market share in 2021.

b: These are some of the target audiences of the global market Kidney function test product manufacturers and distributors, Healthcare institutions (hospitals, academic medical centers, and outpatient clinics), Diagnostic laboratories, Health insurance players, Research and consulting firms, Regulatory bodies, Venture capitalists.

b: The global Kidney function test market is expected to grow at a compound annual growth rate (CAGR) of 6.63 % from 2021 to 2030 to reach USD 1476.53 Million by 2030.

b: The global Kidney function test market size was $ 828.57 Mn in 2021 and is predicted to reach $ 1476.53 Mn by 2030, with a CAGR of 6.63 %.

Sources

https://connect.medrxiv.org/relate/content/181

https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf

https://www.ncqa.org/blog/kidneyhealth/